Nanopharm CEO Jag Shur has announced the addition of three new members of the company's management team in a LinkedIn post. The new hires include two OINDP experts: Dave Farrow, who joins the company as Director of Operations, and Chris Vernall as Director of Business Development. Farrow was most recently Head of Development at Albany Molecular Research, Inc. and … [Read more...] about Nanopharm adds to management team
News
Breath Therapeutics initiates additional studies of inhaled liposomal cyclosporine A for bronchiolitis obliterans
Breath Therapeutics, which was acquired by Zambon in July 2019, said that it has initiated two new trials of its liposomal cyclosporine A for inhalation (L-CsA-i) for the treatment of bronchiolitis obliterans syndrome (BOS). BOSTON-3 is open-label extension study of the Phase 3 BOSTON-1 and BOSTON-2 studies of L-CsA-i for the treatment of BOS after a lung transplant … [Read more...] about Breath Therapeutics initiates additional studies of inhaled liposomal cyclosporine A for bronchiolitis obliterans
RDD returns to California for RDD 2020
OINDP experts will gather once again in Palm Desert, California from April 26-30 for the 2020 edition of the Respiratory Drug Delivery (RDD) conference. As with past RDD meetings, attendees will find a scientific program and poster exhibition featuring the latest in aerosol drug delivery science, a technology exhibition with companies offering products and services, … [Read more...] about RDD returns to California for RDD 2020
Copley Scientific introduces new inhaled dissolution dose collector
Copley Scientific has announced the launch of a new inhaled dissolution dose collector (IDDC) system for the collection of representative samples of particles from MDIs and DPIs for dissolution testing by USP Method 2. The system can collect the impactor sized mass or the fine particle dose, depending on the inlet used. According to Copley, the IDDC works with … [Read more...] about Copley Scientific introduces new inhaled dissolution dose collector
Noble International names Jeffrey Miller as Director, Business Development
Training device and patient onboarding company Noble International, which was acquired by Aptar Pharma in October 2019, has announced the appointment of Jeffrey Miller as Director, Business Development. The company manufactures training devices that mimic marketed MDIs and DPIs that can simulate actuation force and provide feedback for guiding and correcting … [Read more...] about Noble International names Jeffrey Miller as Director, Business Development
Seurat reports data from preclinical studies of intranasal IGF-1
Seurat Therapeutics has published data from studies of its intranasal IGF-1 in rat models for the treatment of migraine in the journal Brain Research. The studies were conducted at the University of Chicago, which has licensed patents for the use of nasal IGF-1 to treat migraines to Seurat. According to the article, the formulation demonstrated the potential of … [Read more...] about Seurat reports data from preclinical studies of intranasal IGF-1
Vectura names Sharon Johnson as Executive VP for Delivery Management
Vectura has announced the appointment of Sharon Johnson to the newly created position of Executive VP for Delivery Management "to support innovation, customer focus and growth as the company continues with its strategic development as a leading inhalation specialist in the pharmaceutical services space." Johnson was most recently Senior VP, Global Quality and … [Read more...] about Vectura names Sharon Johnson as Executive VP for Delivery Management
Nanoform adds US subsidiary
Nanoform, a specialist in nanonization technology, has announced the establishment of a wholly owned US subsidiary, citing growing demand for its technology from US pharma companies. Nanoform recently announced the appointment of former Catalent executive Sally Langa as its new Head of US Sales. In November 2019, Nanoform won the 2019 Excellence in Pharma: … [Read more...] about Nanoform adds US subsidiary
Apollo Global Management agrees to acquire Covis Pharma
Apollo Global Management has agreed to acquire Covis Pharma, which markets several ciclesonide aerosol products: the Alvesco MDI and Omnaris and Zetonna nasal sprays. Terms of the deal were not disclosed. Covis is currently owned by Cerberus Capital Management, which founded the company in 2011. In 2017, Covis acquired the US rights to the three ciclesonide … [Read more...] about Apollo Global Management agrees to acquire Covis Pharma
Boehringer Ingelheim’s reusable Respimat SMI wins 2020 Pharmapack eco-design award
Boehringer Ingelheim's reusable Respimat soft mist inhaler has won the 2020 Pharmapack Eco-Design Award, the company said. As many as six medication cartridges can be used with this version of the Respimat before the device must be replaced, significantly reducing the amount of plastic waste. According to the company, the reusable Respimat is expected to save 776 … [Read more...] about Boehringer Ingelheim’s reusable Respimat SMI wins 2020 Pharmapack eco-design award